z-logo
Premium
Long noncoding RNAs: Important participants and potential therapeutic targets for myocardial ischaemia reperfusion injury
Author(s) -
Ding YuMing,
Chan Elsa Ching,
Liu LiChang,
Liu ZhiWei,
Wang Qiong,
Wang JianLi,
Cui XiaoPei,
Jiang Fan,
Guo XiaoSun
Publication year - 2020
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/1440-1681.13375
Subject(s) - reperfusion injury , myocardial ischemia , long non coding rna , myocardial ischaemia , ischemia , cardiology , myocardial reperfusion injury , medicine , rna , biology , genetics , gene
Myocardial ischaemia reperfusion (I/R) injury is one of the leading causes of coronary artery disease‐associated morbidity and mortality. While different strategies have been used to limit I/R injuries, cardiac functions often do not recover to the normal level as anticipated. Recent studies have pointed to important roles of long noncoding RNAs (lncRNAs) in the development of myocardial I/R injury. LncRNA is a class of RNA molecules of more than 200 nucleotides in length which are not translated into proteins. I/R causes dysregulation of lncRNA expression in cardiomyocytes, thereby affecting multiple cellular functions including mitochondrial homeostasis, apoptosis, necrosis and autophagy, suggesting that manipulating lncRNAs may be of great potential in counteracting I/R injury‐induced myocardial dysfunctions. In this review, we provide an updated summary on our knowledge about contributions of lncRNAs to the development of I/R injury, with an emphasis on the functional links between several well established cardiac lncRNAs and regulation of cellular outcomes post I/R.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom